These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 466642)

  • 1. Antitumor effects of azaserine and DON.
    Burchenal JH
    Cancer Treat Rep; 1979 Jun; 63(6):1031-2. PubMed ID: 466642
    [No Abstract]   [Full Text] [Related]  

  • 2. Azaserine, DON, and azotomycin: three diazo analogs of L-glutamine with clinical antitumor activity.
    Catane R; Von Hoff DD; Glaubiger DL; Muggia FM
    Cancer Treat Rep; 1979 Jun; 63(6):1033-8. PubMed ID: 380801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of 6-diazo-5-oxo-L-norleucine (DON).
    Sklaroff RB; Casper ES; Magill GB; Young CW
    Cancer Treat Rep; 1980; 64(12):1247-51. PubMed ID: 7471114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Joint therapy of experimental tumors with diazan in combination with antibiotics].
    Volkova LM; D'iachkovskaia RF; Konovalova NP
    Antibiotiki; 1979 Apr; 24(4):300-3. PubMed ID: 87148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of N-diazoacetyl derivatives of glycine and phenylalanine against P388 leukemia and B16 melanoma in mice.
    Sava G; Giraldi T; Baldini L
    Cancer Treat Rep; 1982 Jan; 66(1):179-81. PubMed ID: 6796268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I and pharmacokinetic studies of DON.
    Kovach JS; Eagan RT; Powis G; Rubin J; Creagan ET; Moertel CG
    Cancer Treat Rep; 1981; 65(11-12):1031-6. PubMed ID: 7296548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I trial of 6-diazo-5-oxo-L-norleucine (DON) administered by 5-day courses.
    Earhart RH; Koeller JM; Davis HL
    Cancer Treat Rep; 1982 May; 66(5):1215-7. PubMed ID: 7083223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination chemotherapy of experimental leukemia].
    Emanuel' NM; Konovalova NP; D'iachkovskaia RF
    Vopr Onkol; 1977; 23(5):62-6. PubMed ID: 888420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II evaluation of DON (6-diazo-5-oxo-L-norleucine) in patients with advanced colorectal carcinoma.
    Lynch G; Kemeny N; Casper E
    Am J Clin Oncol; 1982 Oct; 5(5):541-3. PubMed ID: 7180833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antineoplastic effect of L-asparaginase].
    Opolski A
    Postepy Hig Med Dosw; 1981; 35(2):177-87. PubMed ID: 7038650
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inactivation of microbial glutamin-(asparagin-)ase by azaserine and 6-diazo-5-oxo-L-norleucine].
    Lebedeva ZI; Kabanova EA; Berezov TT
    Biull Eksp Biol Med; 1985 Dec; 100(12):696-8. PubMed ID: 4074870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy studies with L-asparaginase (NSC-109229) and other antitumor agents.
    Jacobs SP; Wodinsky I; Kensler CJ; Venditti JM
    Cancer Chemother Rep; 1970 Oct; 54(5):329-35. PubMed ID: 5514622
    [No Abstract]   [Full Text] [Related]  

  • 13. [Factor analysis of the effectiveness of combined therapy in experimental leukemia].
    Emanuél' NM; Konovalova NP; Volkova LM; Rusanov VV
    Vopr Onkol; 1979; 25(6):96-100. PubMed ID: 462879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of BCG as an immunoadjuvant in combination with antitumor agents in virus-induced leukemia].
    Sbaraglia G; Cenci E; Vecchiarelli A; Perito S
    Boll Soc Ital Biol Sper; 1980 Oct; 56(19):1969-75. PubMed ID: 7459108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effects of methylglyoxal-bis(N-4-methylthiosemicarbazone) and their potentiation in pyridoxine-deficient animals.
    Mihich E; Nichol CA
    Cancer Res; 1965 Jul; 25(6):794-801. PubMed ID: 5214034
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of 6-diazo-5-oxo-L-norleucine and N-[N-gamma-glutamyl-6-diazo-5-oxo-norleucinyl]-6-diazo-5-oxo-norleucine against experimental tumors in conventional and nude mice.
    Ovejera AA; Houchens DP; Catane R; Sheridan MA; Muggia FM
    Cancer Res; 1979 Aug; 39(8):3220-4. PubMed ID: 572261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies and progress on the enhancement of therapeutic effects of antitumor drugs].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1107-15. PubMed ID: 6408997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental determination of the antileukemic effect of 1,2-bis-diazoacetylethane].
    Emanúel' NM; Gumanov LL; Konovalova NP; D'iachkovskaia PF; Bogdanov GN; Vasil'eva LS; Plugina LA; Orlova ZhI
    Dokl Akad Nauk SSSR; 1968 Nov; 183(3):724-6. PubMed ID: 5747535
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of uric acid biosynthesis in birds by o-diazoacetyl-L-serine (azaserine) and 6-diazo-5-oxo-L-norleucine (DON).
    KRAKOFF IH; KARNOFSKY DA
    Am J Physiol; 1958 Oct; 195(1):244-50. PubMed ID: 13583156
    [No Abstract]   [Full Text] [Related]  

  • 20. 6-diazo-5-oxo-L-norleucine and azaserine as affinity inhibitors of glutamin(asparagin)ase.
    Lebedeva ZI; Kabanova EA; Berezov TT
    Biochem Int; 1986 Mar; 12(3):413-20. PubMed ID: 3707592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.